160 related articles for article (PubMed ID: 33614957)
1. Effectiveness of Puberty Suppression with Gonadotropin-Releasing Hormone Agonists in Transgender Youth.
Mejia-Otero JD; White P; Lopez X
Transgend Health; 2021; 6(1):31-35. PubMed ID: 33614957
[No Abstract] [Full Text] [Related]
2. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
Garibaldi LR; Aceto T; Weber C; Pang S
J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
[TBL] [Abstract][Full Text] [Related]
3. Effect of gonadotropin-releasing hormone analog on ovarian reserve in children with central precocious puberty.
Tao Y; Si C; Li H; Han J; Hou H; Yang M
Ann Palliat Med; 2020 Jan; 9(1):53-62. PubMed ID: 32005063
[TBL] [Abstract][Full Text] [Related]
4. The histrelin implant: a novel treatment for central precocious puberty.
Hirsch HJ; Gillis D; Strich D; Chertin B; Farkas A; Lindenberg T; Gelber H; Spitz IM
Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
[TBL] [Abstract][Full Text] [Related]
5. Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study.
Valenzise M; Nasso C; Scarfone A; Rottura M; Cafarella G; Pallio G; Visalli G; Di Prima E; Nasso E; Squadrito V; Wasniewska M; Irrera P; Arcoraci V; Squadrito F
Front Pediatr; 2023; 11():1170025. PubMed ID: 37266535
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of basal LH in monitoring central precocious puberty treatment in girls.
Calcaterra V; De Filippo G; Albertini R; Rendina D; Messini B; Monti CM; Bozzola E; Villani A; Bozzola M
J Pediatr Endocrinol Metab; 2021 Jan; 34(1):45-50. PubMed ID: 33189082
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial.
Eugster EA; Clarke W; Kletter GB; Lee PA; Neely EK; Reiter EO; Saenger P; Shulman D; Silverman L; Flood L; Gray W; Tierney D
J Clin Endocrinol Metab; 2007 May; 92(5):1697-704. PubMed ID: 17327379
[TBL] [Abstract][Full Text] [Related]
8. Central precocious puberty: a single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment.
Salerno M; Di Maio S; Gasparini N; Mariano A; Macchia V; Tenore A
Horm Res; 1998; 50(4):205-11. PubMed ID: 9838241
[TBL] [Abstract][Full Text] [Related]
9. Growth in Transgender/Gender-Diverse Youth in the First Year of Treatment With Gonadotropin-Releasing Hormone Agonists.
Schulmeister C; Millington K; Kaufman M; Finlayson C; Kennedy JO; Garofalo R; Chan YM; Rosenthal SM
J Adolesc Health; 2022 Jan; 70(1):108-113. PubMed ID: 34315674
[TBL] [Abstract][Full Text] [Related]
10. Serum Levels of Thyroid Stimulating Hormone and Luteinizing Hormone Are Decreased in Girls with Central Precocious Puberty after 12-Month GnRH Agonist Treatment.
Kim YJ; Chung LY; Kang E; Nam HK; Rhie YJ; Lee KH
Tohoku J Exp Med; 2020 Nov; 252(3):193-197. PubMed ID: 33087637
[TBL] [Abstract][Full Text] [Related]
11. Assessment of gonadotrophin suppression in girls treated with GnRH analogue for central precocious puberty; validity of single luteinizing hormone measurement after leuprolide acetate injection.
Demirbilek H; Alikasifoglu A; Gonc NE; Ozon A; Kandemir N
Clin Endocrinol (Oxf); 2012 Jan; 76(1):126-30. PubMed ID: 21790701
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty.
Neely EK; Wilson DM; Lee PA; Stene M; Hintz RL
J Pediatr; 1995 Jul; 127(1):47-52. PubMed ID: 7608810
[TBL] [Abstract][Full Text] [Related]
13. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty.
Lee HS; Yoon JS; Roh JK; Hwang JS
Endocrine; 2016 Nov; 54(2):497-503. PubMed ID: 27444748
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic central precocious puberty with Prader-Willi syndrome: pubertal development with discontinuation of gonadotropin-releasing hormone analog.
Kobayashi M; Yagasaki H; Tamaru K; Mitsui Y; Inukai T
Endocrinol Diabetes Metab Case Rep; 2022 Aug; 2022():. PubMed ID: 36017812
[TBL] [Abstract][Full Text] [Related]
15. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin and Estradiol Levels after Leuprolide Stimulation Tests in Brazilian Girls with Precocious Puberty.
Junqueira FR; Lara LA; Martins WP; Ferriani RA; Rosa-E-Silva AC; de Sá MF; Reis RM
J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):313-6. PubMed ID: 26094907
[TBL] [Abstract][Full Text] [Related]
17. Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty.
Schubert S; Hvelplund AH; Handberg A; Hagstroem S; Leunbach TL
J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):204-211. PubMed ID: 33374097
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin Suppression for 7 Years After a Single Histrelin Implant for Precocious Puberty.
Villalta D; Quintos JB
J Endocr Soc; 2022 Feb; 6(2):bvab189. PubMed ID: 35047716
[TBL] [Abstract][Full Text] [Related]
19. Central precocious puberty: clinical and laboratory features.
Chemaitilly W; Trivin C; Adan L; Gall V; Sainte-Rose C; Brauner R
Clin Endocrinol (Oxf); 2001 Mar; 54(3):289-94. PubMed ID: 11298079
[TBL] [Abstract][Full Text] [Related]
20. The Diagnostic Utility of the Basal Luteinizing Hormone Level and Single 60-Minute Post GnRH Agonist Stimulation Test for Idiopathic Central Precocious Puberty in Girls.
Cao R; Liu J; Fu P; Zhou Y; Li Z; Liu P
Front Endocrinol (Lausanne); 2021; 12():713880. PubMed ID: 34456870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]